Orders from production customers jumped 600% while the street focused on a 25% drop in US academic funding.
Thesis: OXIG is being priced as a cyclical academic supplier, missing the structural mix shift to commercial compound semiconductor production. While H1 looked ugly due to lead time lags, the 'Backlog Fortress' is real (orders up 34% in commercial). With fixed costs covered and margins holding at 55%, the H2 revenue recognition will drive massive operating leverage. The £100m buyback puts a floor under the price while we wait for the print.
Verdict: LONG — Conviction: MEDIUM
Catalyst: H2 earnings confirming the 'early teens' growth in Advanced Technologies and the resulting margin expansion from operational leverage.
Key Risk: Backlog Quality - if the 'timing delays' cited in H1 extend further, the H2 ramp evaporates and the 'structural shift' narrative breaks.
The Tell: The pension fund maneuver. Management quietly confirmed 'no further payments' to the defined benefit scheme, unlocking a £12m cash flow improvement. This non-operating windfall effectively funds the dividend increase and supports the buyback, yet it was delivered as a footnote to the 'clean up'.
Friction Level: HIGH_FRICTION — The disconnect between H1 revenue stagnation (lagging) and the order book surge (leading). Bears see a 'Say/Do Gap', Bulls see a 'Coiled Spring' ready to release in H2.
Report not found
The report data is no longer available. Please return to the archive.